Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage: The prospective observational multicenter ASTRO-DE study
Hans‐Christoph Diener(University of Birmingham), Sven Poli(Hertie Institute for Clinical Brain Research), Ilko Maier(Universitätsmedizin Göttingen), Nils Kuklik(University of Duisburg-Essen), Maria M. Gabriel(Medizinische Hochschule Hannover), Angelika Alonso(Heidelberg University), Anika Hüsing(German Cancer Research Center), Darius G. Nabavi(Vivantes Klinikum)
Cited by 3
Related Papers
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616